Funded Tech Companies

Terns Pharmaceuticals

Looking for the VC firms that invested in Terns Pharmaceuticals? Eli Lilly and Company, Lilly Asia Ventures and OrbiMed joined the equity holders in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer. The company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in China.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

2/5/2021

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Senthil Sundaram

        

Chief Financial Officer

Mark Vignola

        

Chief Medical Officer

Erin Quirk

        

Chief Operating Officer

Bryan Yoon

        

Chief Scientific Officer

Weidong Zhong

        

Company Investors

• Eli Lilly and Company
• Lilly Asia Ventures
• OrbiMed (Carl Gordon)
• Deerfield Capital (Elise Wang)
• Vivo Capital (Shan Fu)
• Suvretta Capital Management
• Samsara BioCapital
• Decheng Capital

Browse more funded tech companies:

TernPro | Terpenoid Therapeutics

Share this article

About Our Venture Capital Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary